ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
Pharmaceuticals

Takara Bio's saliva-based coronavirus test to allow samples taken at home

Expected to be release this month, method would greatly expand testing capacity

Mucus-based PCR testing requires a swab of the nose and throat.    © Reuters

TOKYO -- Takara Bio will release a coronavirus test in Japan as early as this month that uses saliva, enabling samples to be taken from home in what could be a major step toward increased testing and improved health care worker safety.

Current tests require mucus from the nose and throat be collected by trained healthcare workers for PCR testing. The ease of the new test will be useful when gathering samples from millions of people.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more